Market Overview

U.S. Tumor Markers Testing Market Report 2018: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities -


The "2018
U.S. Tumor Markers Testing Market: Supplier Shares and Strategies,
Volume and Sales Segment Forecasts, Emerging Tests, Technologies and
report has been added to's

This new report is a strategic analysis of the major business
opportunities emerging in the cancer diagnostics market during the next
five years. The report examines trends in the US cancer diagnostics
markets; reviews current and emerging tests; analyzes potential
applications of various diagnostic technologies; forecasts sales of
major tumor markers and market segment; profiles leading market players
and potential entrants; and suggests alternative business expansion
strategies for suppliers.


The cancer diagnostics market is on the verge of explosion, as the
researchers approach major technological breakthroughs in tumor
diagnosis and therapy, discover new specific antigens, and unlock the
mystery of the genetic basis of the disease. During the next five years,
the worldwide cancer diagnostics market is promising to be an exciting,
dynamic and rapidly expanding field.

Anticipated technological breakthroughs will create numerous
opportunities for determining genetic predisposition, detecting specific
tumors, and monitoring biological response to cancer therapy. The rise
in geriatric population will further compound the growing demand for
malignancy assays and the rapid market expansion.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially
significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Market Segmentation Analysis

- Sales and market shares of major suppliers, by individual cancer
diagnostic test.

- Five-year test volume and sales forecasts for major cancer diagnostic
tests by market segment, including:

- Hospitals

- Commercial/Private Laboratories

- Physician Offices/Group Practices

- Cancer Clinics

- Comprehensive market segmentation analysis, including review of the
market dynamics, structure, size, growth and major suppliers.

- Cancer statistics, etiology and recent developments.

Current and Emerging Products

Review of over 200 current and emerging cancer diagnostic tests,

- Biochemical Markers

- Oncogenes

- Growth Factors

- Hormones

- Colony Stimulating Factors

- Lymphokines

- Immunohistochemical Stains, and others.

- Analysis of major immunoassay analyzers used for cancer diagnostic
testing, including their operating characteristics, features and selling

Technology Review

- Assessment of monoclonal antibodies, immunoassays, DNA probes,
biochips/microarrays, chromosome analysis, IT, artificial intelligence,
flow cytometry, biosensors, and other technologies and their potential
applications for cancer diagnostic testing.

- Review of competing/complementing technologies, including CT, MRI,
NMR, PET and photonics spectroscopy.

- Extensive listings of over 500 companies, universities and research
centers developing new cancer diagnostic tests and detection

For more information about this report visit

View Comments and Join the Discussion!